Patents by Inventor Kari Ann Shirey

Kari Ann Shirey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR DECREASING INFLUENZA-INDUCED LETHALITY USING GASTRIN-RELEASING PEPTIDE (GRP) INHIBITORS OR GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) ANTAGONISTS
    Publication number: 20220002399
    Abstract: Gastrin-releasing peptide (GRP) is a neuroendocrine peptide that acts as a novel contributor to the inflammatory response to influenza infection. Thus, inhibition of GRP or antagonizing the GRP receptor (GRPR) during influenza infection represents a novel therapeutic approach to mitigating lung damage. The present invention encompasses methods of treatment based on these novel findings and observations.
    Type: Application
    Filed: September 10, 2019
    Publication date: January 6, 2022
    Applicants: University of Maryland, Baltimore, The United Stated of America, as represented by the Secretary, Departmnet of Health and Human Servic
    Inventors: Stefanie N VOGEL, Kari Ann SHIREY, Frank CUTTITTA
  • ADMINISTRATION OF ERITORAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT ORTHOMYXOVIRUS INFECTIONS
    Publication number: 20160022717
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 31, 2015
    Publication date: January 28, 2016
    Applicant: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Stefanie VOGEL, Kari Ann Shirey
  • Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
    Patent number: 9132141
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: September 15, 2015
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Stefanie Vogel, Kari Ann Shirey
  • ADMINISTRATION OF ERITORAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT ORTHOMYXOVIRUS INFECTIONS
    Publication number: 20130261076
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 4, 2013
    Publication date: October 3, 2013
    Applicant: University of Maryland
    Inventors: Stefanie Vogel, Kari Ann Shirey